NCT00404001 - Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

July 31, 2007

Conditions

Hypercholesterolemia

Interventions

DRUG

MD-0727

Trial Locations (20)

Microbia Investigational Site, Birmingham

Microbia Investigational Site, Los Angeles

Microbia Investigational Site, Walnut Creek

Microbia Investigational Site, New Port Richey

Microbia Investigational Site, Chicago

Microbia Investigational Site, Indianapolis

Microbia Investigational Site, Overland

Microbia Investigational Site, Louisville

Microbia Investigational Site, Edina

Microbia Investigational Site, Kansas City

Microbia Investigational Site, Statesville

Microbia Investigational Site, Winston-Salem

Microbia Investigational Site, Cincinnati

Microbia Investigational Site, Marion

Microbia Investigational Site, Charleston

Microbia Investigational Site, Bristol

Microbia Investigational Site, San Antonio

Microbia Investigational Site, Richmond

Microbia Investigational Site, Lakewood

Microbia Investigational Site, Olympia